Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer

Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer

Familial non-medullary thyroid carcinoma (FNMTC) is a type of thyroid cancer characterized by genetic susceptibility, representing approximately 5% of all non-medullary thyroid carcinomas. While some cases of FNMTC are associated with familial multi-organ tumor predisposition syndromes, the majority...

Full description

Bibliographic Details
Main Authors:	Yu-jia Jiang, Yun Xia, Zhuo-jun Han, Yi-xuan Hu, Tao Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Oncology
Subjects:	thyroid carcinoma familial non-medullary thyroid carcinoma chromosomal locus GWAS WES genetic mutation
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1286426/full

Similar Items

RET mutations in a large indian family with medullary thyroid carcinoma
by: D M Mahesh, et al.
Published: (2014-01-01)

Using preoperative ultrasound vascularity characteristics to estimate medullary thyroid cancer
by: Luying Gao, et al.
Published: (2023-06-01)

Metachronous Follicular Variant of Papillary Thyroid Microcarcinoma in a Case of Medullary Carcinoma Thyroid
by: Neelam Sood, et al.
Published: (2016-07-01)

Coexistence of Medullary and Papillary Thyroid Carcinomas Detected Incidentally
by: Ensar Aydemir, et al.
Published: (2021-03-01)

Editorial: The role of genetic alterations in thyroid carcinoma
by: Joachim Feldkamp
Published: (2022-08-01)

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
by: Sun Jung Kim, et al.
Published: (2021-11-01)

Phenotypic Appraisal of Collision Tumors of Thyroid – Initial Experience of a Rare Entity at a Cancer Centre in South India
by: Sherin James, et al.
Published: (2022-05-01)

Overview of management and therapeutic advances in medullary thyroid cancer
by: Mark A Jara, et al.
Published: (2025-03-01)

Hashimoto's Thyroiditis and Medullary Carcinoma of Thyroid
by: Senjuti Dasgupta, et al.
Published: (2014-06-01)

Somatic Mutations in Exons 10, 11, and 16 of the RET Protooncogene in Medullary Thyroid Carcinoma Patients
by: Elham Shakiba, et al.
Published: (2020-09-01)

Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
by: Qin Huang, et al.
Published: (2020-05-01)

An Unusual Combination of Parathyroid Adenoma, Medullary and Papillary Thyroid Carcinoma
by: Nastaran Sabetkish, et al.
Published: (2013-05-01)

An Unusual Combination of Parathyroid Adenoma, Medullary and Papillary Thyroid Carcinoma
by: Nastaran Sabetkish, et al.
Published: (2013-05-01)

A role for radiotherapy in the management of advanced medullary thyroid carcinoma: the Mayo Clinic experience
by: Jason A. Call, et al.
Published: (2013-07-01)

Concurrent Medullary Carcinoma and Hashimoto’s Thyroiditis: A Case Report with an Emphasis on US Features
by: Hyoung Yeob Kim, et al.
Published: (2023-09-01)

Medullary Thyroid Carcinoma in the Background of Non-neoplastic Toxic Nodular Goiter
by: Azra Rizwan, MBBS, FCPS Medicine, MSc Clinical Research, et al.
Published: (2024-11-01)

Mixed medullary—papillary thyroid carcinoma with mixed lymph node metastases: A case report
by: Vanessa Guerreiro, et al.
Published: (2021-05-01)

Familial Medullary Thyroid Carcinoma without MEN Syndrome: A Case Series Study
by: Jamal Jafari Nodooshan, et al.
Published: (2023-04-01)

Distinct Impacts of Clinicopathological and Mutational Profiles on Long-Term Survival and Recurrence in Medullary Thyroid Carcinoma
by: Moon Young Oh, et al.
Published: (2024-12-01)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
by: Wenliang Yue, et al.
Published: (2022-11-01)

Expression of T-cell immunoreceptor with immunoglobulin and tyrosine-based inhibitory motif domains (TIGIT) in anaplastic thyroid carcinoma
by: Tadao Nakazawa, et al.
Published: (2022-08-01)

The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
by: Jialin Zhu, et al.
Published: (2019-07-01)

Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass
by: LI Rui, LIU Zhuoran, YAN Jiqi
Published: (2022-06-01)

Association between RET genotype and disease phenotype in patients with hereditary medullary thyroid carcinoma
by: ZHANG Gang, ZHANG Zhe, ZHANG Shu, LI Zhirong, TIAN Wuguo, HUANG Qi, WANG Lingli, XU Yan
Published: (2021-11-01)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
by: Rafael Loch Batista, et al.
Published: (2013-01-01)

Thirty synchronous medullary and papillary thyroid carcinomas
by: Daqi Zhang, et al.
Published: (2023-03-01)

Diagnostic efficiency of existing guidelines and the AI-SONIC™ artificial intelligence for ultrasound-based risk assessment of thyroid nodules
by: Linxin Yang, et al.
Published: (2023-02-01)

Ultrasonic radiomics in predicting pathologic type for thyroid cancer: a preliminary study using radiomics features for predicting medullary thyroid carcinoma
by: Dai Zhang, et al.
Published: (2025-02-01)

Role of cytology in differentiating anaplastic thyroid carcinoma with osteoclast like giant cells from giant cell variant of medullary thyroid carcinoma
by: G P S Gahlot, et al.
Published: (2020-01-01)

Mixed Medullary-Papillary Thyroid Carcinoma with Mixed Lymph Node Metastases: a Case Report and Review of the Literature
by: Yang Y, et al.
Published: (2024-09-01)

Shear wave elastography in medullary thyroid carcinoma diagnostics
by: Katarzyna Dobruch-Sobczak, et al.
Published: (2015-12-01)

Thyroid Collision Tumors: The Presence of the Medullary Thyroid Carcinoma Component Negatively Influences the Prognosis
by: Ion Negura, et al.
Published: (2023-01-01)

Critically evaluated key points on hereditary medullary thyroid carcinoma
by: Daqi Zhang, et al.
Published: (2024-06-01)

Efficacy and Safety of Pazopanib in the Treatment of Thyroid Cancer: A Systematic Review
by: Alexandra Laura Mederle, et al.
Published: (2024-12-01)

Clinical profile of medullary thyroid carcinoma: Audit from a tertiary care center in South India
by: P R Manjunath, et al.
Published: (2020-01-01)

Diagnosis and treatment of medullary thyroid carcinoma-an update
by: CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben
Published: (2022-06-01)

Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study
by: Daqi Zhang, et al.
Published: (2024-01-01)

Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960–2014: a nationwide study
by: Jes Sloth Mathiesen, et al.
Published: (2018-06-01)

Postoperative Neck Ultrasonography Surveillance After Thyroidectomy in Patients With Medullary Thyroid Carcinoma: A Multicenter Study
by: Hye Shin Ahn, et al.
Published: (2018-03-01)

Histopathological and immunohistochemical features of thyroid carcinoma
by: Tatić Svetislav B.
Published: (2003-01-01)